Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 15 October 1999:
Vol. 286. no. 5439, p. 373
DOI: 10.1126/science.286.5439.373g

This Week in Science

One of the first lines of defense against microbial invaders are the defensins. These small peptides, which are produced by both invertebrates and vertebrates and provide an initial barrier that is bactericidal or bacteristatic (see the Perspective by Ganz), are the subject of a research article and a report. Tang et al. (p. 498) identified an unusual defensin in primates, rhesus theta defensin-1, that is a cyclic peptide. Genetic analysis revealed that the cyclic peptide originates from two separate loci. Two propeptides are produced that ultimately are trimmed and stitched together to form the active cyclic defensin. This unusual form for an animal peptide suggests that enzymes may exist that catalyze the cyclization reaction and, if so, these may not be their only substrates. Yang et al. (p. 525) report that human b-defensins can attract immature dendritic cells and T cells through the use of the CCR6 chemokine receptor, whose only other known ligand is LARC (also called MIP-3a). Thus, these peptides not only provide initial antimicrobial protection, but they attract the cells of adaptive immunity to provide a more efficient immune response.





ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)